Effect of a Selective Abl Tyrosine Kinase Inhibitor, STI571, on in Vitro Growth of BCR-ABL-positive Acute Lymphoblastic Leukemia Cells
Leukemia - United Kingdom
doi 10.1038/sj.leu.2402068
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2001
Authors
Publisher
Springer Science and Business Media LLC